Candelaria, M., Gallardo-Rincón, D., Arce, C., Cetina, L., Aguilar-Ponce, J. L., Arrieta, O., . . . Dueñas-Gonzalez, A. (2007). A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. BioMed Central.
Citação norma ChicagoCandelaria, Myrna, et al. A Phase II Study of Epigenetic Therapy With Hydralazine and Magnesium Valproate to Overcome Chemotherapy Resistance in Refractory Solid Tumors. BioMed Central, 2007.
Citação norma MLACandelaria, Myrna, et al. A Phase II Study of Epigenetic Therapy With Hydralazine and Magnesium Valproate to Overcome Chemotherapy Resistance in Refractory Solid Tumors. BioMed Central, 2007.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.